Bottom line
What does PSCH hold?
PSCH held 81 positions as of May 31, 2026. Its largest holding is Invesco Private Prime Fund at 21.48% of the fund, and the top 10 positions add up to 59.8%. By asset type it is 100% stocks, 30% cash & short-term funds.
Updated Jul 28, 2026
PSCH top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | Cash & short-term funds | 21.48% | $28.2M |
| 2 | Invesco Private Government Fund | Cash & short-term funds | 8.27% | $10.9M |
| 3 | Molina Healthcare, Inc. | Stocks | 4.77% | $6.3M |
| 4 | BrightSpring Health Services, Inc. | Stocks | 4.35% | $5.7M |
| 5 | Krystal Biotech, Inc. | Stocks | 4.25% | $5.6M |
| 6 | Alkermes PLC | Stocks | 3.71% | $4.9M |
| 7 | Corcept Therapeutics Inc. | Stocks | 3.47% | $4.6M |
| 8 | Glaukos Corp. | Stocks | 3.17% | $4.2M |
| 9 | PTC Therapeutics, Inc. | Stocks | 3.16% | $4.2M |
| 10 | Protagonist Therapeutics, Inc. | Stocks | 3.12% | $4.1M |
| 11 | Teleflex Inc. | Stocks | 3.03% | $4.0M |
| 12 | TG Therapeutics, Inc. | Stocks | 2.75% | $3.6M |
| 13 | Ligand Pharmaceuticals Inc. | Stocks | 2.43% | $3.2M |
| 14 | Indivior Pharmaceuticals, Inc. | Stocks | 2.40% | $3.2M |
| 15 | RadNet, Inc. | Stocks | 2.06% | $2.7M |
| 16 | Merit Medical Systems, Inc. | Stocks | 1.99% | $2.6M |
| 17 | Veracyte, Inc. | Stocks | 1.95% | $2.6M |
| 18 | Catalyst Pharmaceuticals, Inc. | Stocks | 1.92% | $2.5M |
| 19 | Organon & Co. | Stocks | 1.85% | $2.4M |
| 20 | ICU Medical, Inc. | Stocks | 1.78% | $2.3M |
| 21 | Integer Holdings Corp. | Stocks | 1.67% | $2.2M |
| 22 | Concentra Group Holdings Parent, Inc. | Stocks | 1.58% | $2.1M |
| 23 | Acadia Pharmaceuticals Inc. | Stocks | 1.45% | $1.9M |
| 24 | Supernus Pharmaceuticals, Inc. | Stocks | 1.41% | $1.9M |
| 25 | Privia Health Group, Inc. | Stocks | 1.33% | $1.7M |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 28, 2026